Derek Jones1. 1. Division of Dermatology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA.
Abstract
BACKGROUND: Human immunodeficiency virus (HIV)-associated facial lipoatrophy is becoming epidemic and may seriously affect quality of life. OBJECTIVE: To review the possible causes and treatment options for HIV facial lipoatrophy. METHODS: This article is based on a review of the medical literature and the author's clinical experience in treating HIV facial CONCLUSION: Although absorbable injectable fillers and implants are helpful in treating HIV facial lipoatrophy, they are limited by cost and the short duration of correction. Newer forms of longer-lasting fillers (poly-L-lactic acid [Sculptra]) and permanent injectable fillers (liquid injectable silicone) are proving useful for treatment of this condition.
BACKGROUND:Human immunodeficiency virus (HIV)-associated facial lipoatrophy is becoming epidemic and may seriously affect quality of life. OBJECTIVE: To review the possible causes and treatment options for HIV facial lipoatrophy. METHODS: This article is based on a review of the medical literature and the author's clinical experience in treating HIV facial CONCLUSION: Although absorbable injectable fillers and implants are helpful in treating HIV facial lipoatrophy, they are limited by cost and the short duration of correction. Newer forms of longer-lasting fillers (poly-L-lactic acid [Sculptra]) and permanent injectable fillers (liquid injectable silicone) are proving useful for treatment of this condition.